Imvax

1 follower

‌

Imvax is a clinical-stage biotechnology company with a unique immunotherapy approach to solid tumors.

Industries

Biotechnology

Headquarters

Philadelphia, United States

Employees

11-50

Links

Org chart

John P. Furey

CEO

John P. Furey

Collapse

Sean Hemingway

COO

Josh Muntner

CFO

David W. Andrews

Co-Founder & Chief Medical Officer

Mark Exley

Chief Scientific Officer

John M. Limongelli

Chief Legal Officer

Diana Martine

Head, Human Resources

Anthony Zuccarello, MBA, PMP, CSM

Head of Supply Chain, Logistics, Procurement & Planning

Charles D. Littleton Jr., MAS

Facility Management Lead (Director)

Jeff Geibel

Head Of Information Technology

Kevin Mizell, MS

Clinical Oversight Lead

Nehal K.

Program Management Lead

Raechel Manrodt

Technical Operations Phase 3 Readiness Lead (director)

Samantha Garcia Smith

Process Development Analysis Lead

Sarah Marcucci

Quality Control Manager, Microbiology

Teams

Management and Coordination

11 members

Scientific and Technical Roles

8 members

Leadership Team

7 members

Clinical Operations and Research

4 members

Finance and Accounting

3 members

Legal and Administrative Functions

3 members

Similar companies

Thermo Fisher Scientific

166 followers

Genentech

150 followers

Biogen

114 followers

Agilent Technologies

63 followers

Avantor

10 followers

Calico

6 followers

Merck

215 followers

AbbVie

177 followers

Apogee Therapeutics

1 follower

Relay Therapeutics

1 follower

Anthropic

57 followers

Explore companies